CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
28.13
17-5月-24 14:59:59
15 分の遅延
株式
+0.59
+2.14%
本日の幅
27.53 - 28.33
ISIN
N/A
ソース
NASDAQ
-
14 2 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
13 2 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Miricorilant Clinical Development Update
08 12 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Settles Patent Litigation with Hikma Pharmaceuticals
08 12 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
03 11 2022 15:05:02 提供 Nasdaq GlobeNewswire
-
27 10 2022 15:05:01 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Initiates DAZALS – A Phase 2 Trial in Amyotrophic Lateral Sclerosis (ALS)
11 10 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
03 8 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
29 6 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
06 6 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces First Quarter Financial Results And Provides Corporate Update
05 5 2022 15:05:01 提供 Nasdaq GlobeNewswire
-
28 4 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Appointment of Three Senior Leaders
07 4 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
04 4 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
30 3 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics to Host Ovarian Cancer Program Update on Thursday, March 31, 2022
01 3 2022 15:05:01 提供 Nasdaq GlobeNewswire
-
15 2 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
08 2 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Final Results of Previously Announced Tender Offer
20 12 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Preliminary Results of Previously Announced Tender Offer
16 12 2021 07:00:02 提供 Nasdaq GlobeNewswire